CBT
GMAB icon

Capital Bank & Trust’s Genmab GMAB Stock Holding History

Capital Bank & Trust’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,134
Closed -$45K – 425
2020
Q1 		$45K Sell
2,134
-400
-16% -$8.92K ﹤0.01% 421
2019
Q4 		$57K Sell
2,534
-25
-1% -$546 ﹤0.01% 431
2019
Q3 		$52K Buy
+2,559
New +$50.4K ﹤0.01% 431

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Capital Bank & Trust's GMAB Position: Q2 2020 in Review

Capital Bank & Trust sold out of Genmab (GMAB) in Q2 2020, closing a stake of 2,134 shares — an estimated $45K sold.

Capital Bank & Trust first reported a position in GMAB in Q3 2019 and held it in 3 quarters. The position peaked at $57K in Q4 2019. 174 funds tracked by Wall St. Rank hold GMAB as of Q2 2020.

  • Capital Bank & Trust reported no remaining Genmab position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 2,134 Genmab shares in Q2 2020, an estimated $45K.
  • Capital Bank & Trust first reported a position in Genmab in Q3 2019 and held it in 3 quarters.
  • Capital Bank & Trust's Genmab position peaked at $57K in Q4 2019.
  • 174 funds tracked by Wall St. Rank held Genmab as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.